Table:
begin	end	state
1	12	non-cytoplasmic
13	42	transmembrane
43	53	cytoplasmic
54	75	transmembrane
76	102	non-cytoplasmic
103	127	transmembrane
128	134	cytoplasmic
135	156	transmembrane
157	161	non-cytoplasmic
162	181	transmembrane
182	192	cytoplasmic
193	216	transmembrane
217	254	non-cytoplasmic
255	278	transmembrane
279	314	cytoplasmic
315	338	transmembrane
339	350	non-cytoplasmic
351	374	transmembrane
375	380	cytoplasmic
381	403	transmembrane
404	409	non-cytoplasmic
410	439	transmembrane
440	459	cytoplasmic
460	483	transmembrane
484	500	non-cytoplasmic

Input:
>WP_086511815.1 NCBI__GCF_002151265.1:WP_086511815.1
MQGFATSLTFSNILAALVGAGLGIIVGAIPGLGSVTGIALLLPLTFQMDPITGIIMLGAL
YYGCMYGGSYSAILLNIPGDAPAVVTSLDGYPLSQQGHGGKALFTANISSFIGGTVGIIM
LTFMGPILAHVGLMFGPAEVAALILLALCSIGWLLGDNPLKGLISTFIGVMLATIGIGTA
FGQPRFTFDSMYLLNGISFIPLVIGMFGFSQVLVMMVNRVDPSAKGLSGRLGLKESLLDR
KEALSILPVSLRSGVLGNLVGILPGAGATTGSFLSYVLEKKVGRNGDELGKGRIQGVAAS
EAGNNAAAAGSFAPLLSLGIPGSGTAAVLLGGLMMWGLQPGPLLFQNNPDFVWGLISSMY
LGNVMAVLAALAIIPFLVKLLLIPASIMIPVIAVVCVVGSYSVNNSMFDVWFMLGAGVVA
FFMTAARYPIAPLLLAFVLTPRLETSLRQALDISRGDPMIFLRSPIAATLLTLILLFVLY
PLAKRLFMTVRRRGHKAAAE

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server